| Members |
targetComponentId |
| International Federation of Gynecology and Obstetrics vulvar carcinoma stage I |
I |
| International Federation of Gynecology and Obstetrics vulvar carcinoma stage II |
American Joint Committee on Cancer stage II (qualifier value) |
| International Federation of Gynecology and Obstetrics vulvar carcinoma stage III |
American Joint Committee on Cancer stage III (qualifier value) |
| International Federation of Gynecology and Obstetrics vulvar carcinoma stage IV |
IV |
| International Federation of Gynecology and Obstetrics vulvar melanoma stage I |
I |
| International Federation of Gynecology and Obstetrics vulvar melanoma stage II |
American Joint Committee on Cancer stage II (qualifier value) |
| International Federation of Gynecology and Obstetrics vulvar melanoma stage III |
American Joint Committee on Cancer stage III (qualifier value) |
| International Federation of Gynecology and Obstetrics vulvar melanoma stage IV |
IV |
| Intersphincteric anal canal dissection |
Dissection - action |
| Intertarsal joint |
Intertarsal joint structure |
| radiologie d'intervention |
Imaging guidance |
| Intervertebral disc extrusion |
Intervertebral disc prolapse |
| Intestinal infection due to Enterobacter aerogenes |
Intestinal infection caused by Klebsiella aerogenes |
| Intestinal infection due to other organisms |
Infectious enteritis of intestine |
| Intra-abdominal flap |
Flap (substance) |
| Intra-amniotic fetal infection |
Intra-amniotic infection of fetus |
| injection intracavitaire |
Injection |
| voie intracaverneuse du pénis |
Intracorporus cavernosum route (qualifier value) |
| Intracranial hemorrhage following injury with open intracranial wound and unspecified state of consciousness |
Intracranial hemorrhage following injury with open intracranial wound |
| Intractable absence seizures |
Absence seizure |
| Intracystic carcinoma |
Encapsulated papillary carcinoma (morphologic abnormality) |
| Intraductal carcinoma, noninfiltrating, no International Classification of Diseases for Oncology subtype |
Non-infiltrating intraductal carcinoma |
| Intraductal papillary-mucinous tumor with moderate dysplasia |
Intraductal papillary-mucinous adenoma (morphologic abnormality) |
| Intramuscular injection of Rh immune globulin |
Intramuscular injection of human anti-D immunoglobulin |
| Intramuscular testosterone allergy |
Allergy to testosterone |
| Intranasal intubation of lacrimal apparatus for tear drainage |
Intranasal intubation of lacrimal drainage system for tear drainage (procedure) |
| Intraoperative echography |
Intraoperative ultrasonography (procedure) |
| Intraoral flap |
Flap (substance) |
| Intraperitoneal placement |
Insertion - action (qualifier value) |
| Intrapetrosal drainage |
Drainage of petrous apex of mastoid |
| Intrapetrosal drainage |
Drainage of petrous apex of mastoid |
| Intrapleural aerosol talc powder 5g/100mL vial |
Product containing only talc (medicinal product) |
| Intravascular bronchial alveolar tumor |
Epithelioid hemangioendothelioma, malignant (morphologic abnormality) |
| Intravascular hemolysis |
Intravascular hemolysis |
| Intravenous infusion of Rh immune globulin |
Intravenous infusion of human anti-D immunoglobulin |
| Intravenous intake process |
Administration of substance via intravenous route (procedure) |
| Intravenous nutrition (electrolytes/trace elements) allergy |
Allergy to drug |
| Intravenous nutrition carbohydrate agent |
Carbohydrate |
| Intravenous nutrition electrolyte agent |
Electrolyte |
| Intravenous nutrition fat agent |
Fat and oil |
| Intraventricular (nontraumatic) hemorrhage, grade 1, of fetus and newborn |
Non-traumatic intraventricular hemorrhage grade 1 during intrapartum and/or early neonatal period (disorder) |
| Intraventricular (nontraumatic) hemorrhage, grade 2, of fetus and newborn |
Non-traumatic intraventricular hemorrhage grade 2 during intrapartum and/or early neonatal period (disorder) |
| Intraventricular (nontraumatic) hemorrhage, grade 3, of fetus and newborn |
Non-traumatic intraventricular hemorrhage grade 3 during intrapartum and/or early neonatal period (disorder) |
| asthme intrinsèque avec état de mal asthmatique |
Acute severe exacerbation of intrinsic asthma (disorder) |
| Intrinsic factor concentrate agent |
Intrinsic factor |
| Introduction into organ NOC therapeutic: [implant] or [substance] |
Introduction procedure (procedure) |
| Introduction of Mirena coil |
Insertion of hormone releasing intrauterine contraceptive device |
| Introduction of catheter into inferior vena cava |
Inferior vena cava catheterization |
| Introduction of gold seeds into organ NOC |
Introduction procedure (procedure) |
| Introduction of iridium wire into organ NOC |
Introduction procedure (procedure) |
| Introduction of non-removable material into organ NOC |
Introduction procedure (procedure) |
| Introduction of non-removable material into organ NOC NOS |
Introduction procedure (procedure) |
| Introduction of radioactive cesium into organ NOC |
Introduction procedure (procedure) |
| Introduction of radium into organ NOC |
Introduction procedure (procedure) |
| Introduction of removable radioactive material into organ NOC |
Introduction procedure (procedure) |
| Introduction of removable radioactive material into organ not otherwise classifiable, NOS |
Introduction procedure (procedure) |
| introduction d'une substance par une localisation corporelle |
Introduction procedure (procedure) |
| Introduction of therapeutic implant into organ NOC |
Introduction procedure (procedure) |
| introduction d'une substance thérapeutique dans le tissu mou |
Introduction procedure (procedure) |
| Introduction of therapeutic substance into subcutaneous tissue NOS |
Introduction of substance into subcutaneous tissue |
| Intron |
Finding related to molecular sequence data |
| Invasion of mesorectum by tumor not applicable |
Intactness of mesorectal specimen not applicable (finding) |
| Invasive medical procedure |
Procedure |
| Invasive procedure |
Procedure |
| Investigational new drug 1990 |
Pharmaceutical / biologic product (product) |
| Iodinated[125I] human albumin >148kBq/mL injection+syringe |
Product containing only iodinated (125-I) human serum albumin in parenteral dose form (medicinal product form) |
| Iodine 0.7%/isopropyl alcohol 74% w/w topical solution |
Iodine and isopropyl alcohol only product |
| Iodine-induced hyperthyroidism |
Iodine-induced hyperthyroidism |
| Iodipamide meglumine 52% injection solution vial |
Product containing only iodipamide (medicinal product) |
| Iodixanol 270mg (I) / mL injection solution vial |
Product containing only iodixanol (medicinal product) |
| Iodixanol 270mg injection |
Product containing only iodixanol (medicinal product) |
| Iodixanol 270mg(I)/mL injection |
Product containing only iodixanol (medicinal product) |
| Iodixanol 270mgi/mL injection |
Product containing only iodixanol (medicinal product) |
| Iodixanol 320mg (I) / mL injection solution vial |
Product containing only iodixanol (medicinal product) |
| Iodixanol 320mg(I)/mL injection |
Product containing only iodixanol (medicinal product) |
| Iodixanol 320mgi/mL injection |
Product containing only iodixanol (medicinal product) |
| Iohexo 240mgi injection solution vial |
Iohexol only product in parenteral dose form |
| Iohexol 140mg (I) / mL injection solution vial |
Iohexol only product in parenteral dose form |
| Iohexol 140mg(I)/mL injection |
Iohexol only product in parenteral dose form |
| Iohexol 140mg(I)/mL injection |
Iohexol only product in parenteral dose form |
| Iohexol 140mgi injection solution vial |
Iohexol only product in parenteral dose form |
| Iohexol 180mg(I)/mL injection |
Iohexol only product in parenteral dose form |
| Iohexol 180mg(I)/mL injection solution vial |
Iohexol only product in parenteral dose form |
| Iohexol 180mgi injection solution vial |
Iohexol only product in parenteral dose form |
| Iohexol 240mg(I)/mL injection |
Iohexol only product in parenteral dose form |
| Iohexol 240mg(I)/mL injection |
Iohexol only product in parenteral dose form |
| Iohexol 240mg(I)/mL injection solution vial |
Iohexol only product in parenteral dose form |
| Iohexol 300mg (I) / mL injection solution vial |
Iohexol only product in parenteral dose form |
| Iohexol 300mg(I)/mL injection |
Iohexol only product in parenteral dose form |
| Iohexol 300mg(I)/mL injection |
Iohexol only product in parenteral dose form |
| Iohexol 300mgi injection solution vial |
Iohexol only product in parenteral dose form |
| Iohexol 350mg (I) / mL injection |
Iohexol only product in parenteral dose form |
| Iohexol 350mg(I)/mL injection |
Iohexol only product in parenteral dose form |
| Iohexol 350mg(I)/mL injection |
Iohexol only product in parenteral dose form |
| Iohexol 350mgi injection solution vial |
Iohexol only product in parenteral dose form |
| Iomeprol 150mg(I)/mL injection solution |
Product containing only iomeprol (medicinal product) |
| Iomeprol 150mg(I)/mL injection solution bottle |
Product containing only iomeprol (medicinal product) |
| Iomeprol 200mg(I)/mL injection solution bottle |
Product containing only iomeprol (medicinal product) |
| Iomeprol 250mg(I)/mL injection solution |
Product containing only iomeprol (medicinal product) |
| Iomeprol 250mg(I)/mL injection solution 50 mL bottle |
Product containing only iomeprol (medicinal product) |
| Iomeprol 250mg(I)/mL injection solution bottle |
Product containing only iomeprol (medicinal product) |
FHIR